Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Parkinson's disease: progressive and clinically heterogeneous
Individualized management of motor and non-motor symptoms
- Type 2 diabetes and heart failure: a bidirectional relationship
Proactive preventive measures can reduce the burden of disease
- Dementia
Delirium risks and treatment strategies
- Colorectal cancer screening
Results of the population-based PREEMPT-CRC study
- Study report: TBS v3 and v4 in comparison
Analysis of OsteoLaus study data
- Atopic dermatitis: proven therapeutic principles and innovations
From healthcare research to precision medicine
- SGLT2 inhibitors and glucocorticoids
Protective effect on kidney function is maintained
- Study report: Nicotinamide for skin cancer prevention